The Cigna Group (NYSE:CI - Get Free Report) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating in a note issued to investors on Thursday, Marketbeat.com reports. They presently have a $323.00 price objective on the health services provider's stock. Sanford C. Bernstein's price objective would indicate a potential upside of 12.67% from the company's current price.
CI has been the topic of several other reports. Raymond James reiterated a "strong-buy" rating and issued a $360.00 target price (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. StockNews.com downgraded The Cigna Group from a "buy" rating to a "hold" rating in a research note on Friday, January 31st. Barclays decreased their target price on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Royal Bank of Canada decreased their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a report on Monday, November 4th. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, The Cigna Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $373.69.
Read Our Latest Stock Analysis on CI
The Cigna Group Price Performance
Shares of CI traded down $0.56 during mid-day trading on Thursday, reaching $286.67. The company had a trading volume of 1,271,913 shares, compared to its average volume of 1,953,796. The company's 50-day moving average is $289.85 and its 200-day moving average is $322.63. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The company has a market capitalization of $79.74 billion, a P/E ratio of 23.42, a P/E/G ratio of 0.94 and a beta of 0.54. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.
The Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter last year, the firm posted $6.79 EPS. On average, equities analysts anticipate that The Cigna Group will post 29.8 EPS for the current year.
Hedge Funds Weigh In On The Cigna Group
Large investors have recently made changes to their positions in the company. Collier Financial acquired a new position in shares of The Cigna Group during the 4th quarter worth approximately $32,000. ORG Wealth Partners LLC bought a new stake in shares of The Cigna Group in the fourth quarter valued at approximately $34,000. Ulland Investment Advisors LLC increased its stake in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock worth $36,000 after acquiring an additional 100 shares during the period. Prospera Private Wealth LLC acquired a new position in The Cigna Group in the 3rd quarter valued at $37,000. Finally, Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group during the 4th quarter valued at $37,000. Institutional investors own 86.99% of the company's stock.
About The Cigna Group
(
Get Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
